Home » Topics » BioWorld

BioWorld
RSS

AMOCO UNIT ACQUIRES ECOVA CORP

Feb. 18, 1992

HYCOR GETS HISTAMINE TECHNOLOGY

Feb. 18, 1992

PRIVATE PLACEMENT RAISES $11.6M

Feb. 18, 1992

CYTOTHERAPEUTICS FILES FOR IPO

Feb. 18, 1992

TRANSGENIC DEVELOPER MAKING IPO .

Feb. 18, 1992

LIPO FILES TO OFFER 3M SHARES

Feb. 18, 1992

$29M OFFERING BY ADVANCED TISSUE

Feb. 18, 1992

CYTORAD SPIN-OFF RAISES $35M

Feb. 18, 1992

NEW REPORT ON SEPSIS LIFE SAVER

Feb. 18, 1992

U.S. BIOSCIENCE STILL WAITING FOR FDA MEETING

Feb. 18, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.